Pinkerton Ross, Hardy Janet R
Hummingbird House Children's Hospice, Brisbane, Queensland, Australia.
Palliative and Supportive Care Services, Mater Cancer Care Centre, Brisbane, Queensland, Australia.
Intern Med J. 2017 Jun;47(6):632-636. doi: 10.1111/imj.13449.
In the context of a therapeutic opioid epidemic, particularly in the USA, where increasingly stringent screening for 'at risk' individuals and close monitoring of opioid prescription and use is strongly recommended, the issue of misuse within the cancer population must be addressed. Most patients with advanced cancer will have pain requiring opioid therapy at some stage during their disease course. In the majority, this will provide good pain relief with no short- or longer-term adverse sequelae. A subset will present with substance misuse issues that will influence management and prescribing practice. The potential ethical issues of limiting effective analgesia on the basis of addiction risk or history must be acknowledged. Both a judgemental or 'relaxed' approach to such patients is problematic. Ignoring the situation will not be in the patient's best interest, but an undue focus on this aspect may damage therapeutic relationships with clinicians and adversely affect a holistic approach to care. Clinical practitioners must be aware of the risk factors for opioid misuse and in patients who are not under palliative care consider screening prior to commencing opioids. Clinicians must be able to manage and monitor those identified as having an opioid misuse problem.
在治疗性阿片类药物泛滥的背景下,尤其是在美国,强烈建议对“高危”个体进行越来越严格的筛查,并密切监测阿片类药物的处方和使用情况,癌症患者群体中的药物滥用问题必须得到解决。大多数晚期癌症患者在病程的某个阶段会出现需要阿片类药物治疗的疼痛。在大多数情况下,这将提供良好的疼痛缓解效果,且不会产生短期或长期的不良后果。有一部分患者会出现药物滥用问题,这将影响治疗管理和处方实践。必须认识到基于成瘾风险或病史限制有效镇痛的潜在伦理问题。对这类患者采取评判性或“宽松”的方法都存在问题。忽视这种情况不符合患者的最佳利益,但过度关注这一方面可能会损害与临床医生的治疗关系,并对整体护理方法产生不利影响。临床医生必须了解阿片类药物滥用的风险因素,对于未接受姑息治疗的患者,在开始使用阿片类药物之前考虑进行筛查。临床医生必须能够管理和监测那些被确定有阿片类药物滥用问题的患者。